New schizophrenia drug shows promise in 6-week trial
NCT ID NCT02477020
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new drug called TAK-063 can help people with schizophrenia who are having a sudden worsening of symptoms. 164 adults took either the drug or a placebo for 6 weeks. The main goal was to see if symptoms improved using a standard rating scale. The study is complete, and results will show if TAK-063 is safe and effective for short-term symptom control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Springdale, Alaska, United States
-
Study site
Culver City, California, United States
-
Study site
Lemon Grove, California, United States
-
Study site
Long Beach, California, United States
-
Study site
Pico Rivera, California, United States
-
Study site
Lauderhill, Florida, United States
-
Study site
Orlando, Florida, United States
-
Study site
Atlanta, Georgia, United States
-
Study site
Lake Charles, Louisiana, United States
-
Study site
St Louis, Missouri, United States
-
Study site
Las Vegas, Nevada, United States
-
Study site
Oklahoma City, Oklahoma, United States
-
Study site
Austin, Texas, United States
-
Study site
Dallas, Texas, United States
-
Study site
Houston, Texas, United States